Feasibility of Intraoperative Neuromonitoring during Thyroid Surgery after Administration of Sugammadex for Reversal of Neuromuscular Blockade
Abstract Background Neuromuscular blocking agent (NMB) dosage suggested in current intraoperative neural monitoring (IONM) clinical guideline might cause operational difficulty during thyroid surgery. This study evaluated the feasibility of sugammadex with an enhanced NMB recovery protocol. Methods Complete IONM data for 57 patients who had normal cord mobility were investigated: 32 patients received rocuronium 0.6 mg/kg at anesthesia induction and sugammadex 2 mg/kg at vagus nerve exposure (group S) and 25 received rocuronium 0.3mg/kg with 0.9% NaCl 2mL/kg instead (group R). Electromyography (EMG) signals were obtained from the vagus nerve and RLN before and after resection of the thyroid lobe and were defined as V1, V2 and R1, R2 signals, respectively. The train-of-four ratio (TOFr) was used for continuous quantitative monitoring of neuromuscular transmission. Results Mean EMG in Group S (vagus nerve: 722.728 ± 160.11μV, RLN: 1028.64 ± 180.34μV) was greater than Group R (568.884 ± 135.15, 776.66 ± 145.91μV) from first minute after administration of sugammadex (P <0.05). The time for tracheal intubation was 102.97±64.5 seconds in group S with high dose rocuronium, while 195.12±68.9 seconds in group R (p < .001). Conclusions Rocuronium 0.6 mg/kg can greatly shorten the tracheal intubation time and reduce the difficulty of surgery, and employment sugammadex can reverse residual muscle relaxation of rocuronium and optimize IONM conditions.